Publication:
Topical glucocorticoid reduces the topical decongestant-induced histologic changes in an animal model nasal mucosa

dc.contributor.authorAKAKIN, DİLEK
dc.contributor.authorÖZKAN YENAL, NAZİYE
dc.contributor.authorŞEHİRLİ, ÜMİT SÜLEYMAN
dc.contributor.authorsAkpinar, Meltem Esen; Yigit, Ozgur; Akakin, Dilek; Sarioz, Ozlem; Ozkan, Naziye; Yildiz, Sercan D.; Azizli, Elad; Sehirli, Umit S.
dc.date.accessioned2022-03-12T16:13:52Z
dc.date.accessioned2026-01-11T11:12:08Z
dc.date.available2022-03-12T16:13:52Z
dc.date.issued2012
dc.description.abstractObjectives/Hypothesis: To investigate the histologic consequences of simultaneous nasal glucocorticosteroid and xylometazoline HCl administration in the rabbit nasal mucosa. Study Design: Prospective randomized study. Methods: Twenty New Zealand male rabbits were randomly placed into three groups: group I, control (n 6); group II, xylometazoline HCl (n 8); or group III, xylometazoline HCl- fluticasone furoate (n 6). Group I received no treatment. Groups II and III received two intranasal puffs of xylometazoline HCl 0.5 mg/ mL twice daily or two puffs of xylometazoline HCl 0.5 mg/ mL twice daily plus one puff of 27.5 lg fluticasone furoate twice daily to each nostril (110 lg), respectively. At the end of 3 weeks, the rabbits were sacrificed. The mucosa of the nasal cavities was excised. Specimen sections (5 lm) were stained with hematoxylin and eosin, mucicarmine, and Gomori one- step trichrome and were examined under a light microscope. The presence of edema, congestion, inflammatory cell infiltration, nasociliary loss, epithelial and nerve- ending degeneration, and goblet cell increase were evaluated semiquantitatively (grades 0- 3). Results: Statistically significant differences were detected between groups II and III in terms of edema, congestion, inflammatory cell infiltration, nasociliary loss, and epithelial degeneration (P.006, P.049, P.015, P.014, and P.049, respectively). Nerve- ending degeneration, goblet cell increase, and quantitative goblet and neutrophil cell counts did not yield statistically significant differences between groups II and III (P.137, P.580, P.770, and P.616, respectively). Conclusions: The combined simultaneous intranasal administration of xylometazoline HCl and fluticasone furoate appears to be beneficial in minimizing the long- term usage- associated congestion, edema, inflammatory cell infiltration, epithelial degeneration, and nasociliary loss in the rabbit model nasal mucosa.
dc.identifier.doi10.1002/lary.23207
dc.identifier.eissn1531-4995
dc.identifier.issn0023-852X
dc.identifier.pubmed22374848
dc.identifier.urihttps://hdl.handle.net/11424/225122
dc.identifier.wosWOS:000301714800008
dc.language.isoeng
dc.publisherWILEY
dc.relation.ispartofLARYNGOSCOPE
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectNasal mucosa
dc.subjectrhinitis medicamentosa
dc.subjectcongestion
dc.subjectdecongestant
dc.subjectnasal steroid
dc.subjectrebound
dc.subjectedema
dc.subjectLevel of Evidence: 2c
dc.subjectRHINITIS-MEDICAMENTOSA
dc.subjectBENZALKONIUM CHLORIDE
dc.subjectREBOUND CONGESTION
dc.subjectALLERGIC RHINITIS
dc.subjectOXYMETAZOLINE
dc.subjectSPRAY
dc.subjectTACHYPHYLAXIS
dc.subjectMECHANISM
dc.subjectSYMPTOMS
dc.subjectEFFICACY
dc.titleTopical glucocorticoid reduces the topical decongestant-induced histologic changes in an animal model nasal mucosa
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage746
oaire.citation.issue4
oaire.citation.startPage741
oaire.citation.titleLARYNGOSCOPE
oaire.citation.volume122

Files